Respostas fisiológicas e de desempenho de leitões suplementados com B-glucanos e desafiados imunologicamente / Phisiologial responses and growth performance of immune challenged piglets supplemented with B-glucans

O estudo buscou avaliar as respostas fisiológicas e de desempenho à adição de diferentes níveis de β-glucanos na dieta de leitões recém-desmamados. Foram utilizados 30 machos de linhagem comercial, com 34 dias de idade e peso de 10,9±0,63kg, alojados em gaiolas individuais, durante 14 dias. Os tratamentos variaram somente nos níveis de β-glucanos que foram de 35, 70, 140 e 280g/T. No final desse período, em metade dos animais foram injetados 2,7mg de lipopolissacarídeo (LPS) em 1mL de solução (PBS)/leitão, e nos demais 1mL/leitão de PBS. Foram avaliadas temperatura retal (TR), frequência respiratória (FR), perfil bioquímico sanguíneo e sinais clínicos aos 30, 90, 120 e 390 minutos seguintes à injeção. As respostas de desempenho não foram afetadas pelos níveis de β-glucanos. Foi observado o aumento de TR, tanto em função do LPS como em função da hora em que a temperatura foi medida. No entanto, os animais LPS-injetados, que receberam 280g/T de β-glucanos, tiveram a mesma TR daqueles LPS-não injetados. Os sinais clínicos foram compatíveis com um quadro de inflamação aguda e foram observados, nos animais LPS-injetados, vômito, prostração e diarreia, sendo que a inclusão de β-glucanos não conseguiu reverter esses sintomas. O uso de β-glucanos por 14 dias na dieta de leitões recém-desmamados mostrou um efeito anti-inflamatório em situação de desafio agudo. Para reverter o desafio imunológico utilizado, o nível de 280g/T de β-glucanos mostrou-se o mais recomendado.

This study was done to evaluate immunological responses and performance of weaning piglets receiving diets with different levels of β-glucans. Thirty males from a commercial line with 34 days of age and 10.9±0,6kg initial weight were housed in individual metabolic cages during 14 days. The treatments only differed in β-glucans levels: 35; 70; 140 and 280g/T. On the 14th day, half of the pigs were inoculated with 2.7mg LPS (lipopolysaccharide)/mL of solution (PBS)/pig and the other half received 1mL PBS/pig. Rectal temperature (RT), respiratory frequency (RF), biochemical profile and animal behavior (120 and 390 minutes after LPS inoculation) were evaluated. As the experiment was conducted, performance was not affected by β-glucans. An RT increase was observed due to LPS and time of temperature measurement. LPS-injected animals receiving 280g/T of β-glucans had the same RT as the LPS- non injected group. Clinical signs were near the expectation for acute inflammation. LPS-injected presented prostration, diarrhea and vomit and the β-glucans did not reverse this situation. The use of β-glucans in weaning pigs for fourteen days showed an anti-inflammatory action. To revert the immunologic challenge, the level of 280g/T of β-glucans was the most recommended.

Respostas fisiológicas e de desempenho de leitões suplementados com B-glucanos e desafiados imunologicamente / Phisiologial responses and growth performance of immune challenged piglets supplemented with B-glucans

O estudo buscou avaliar as respostas fisiológicas e de desempenho à adição de diferentes níveis de β-glucanos na dieta de leitões recém-desmamados. Foram utilizados 30 machos de linhagem comercial, com 34 dias de idade e peso de 10,9±0,63kg, alojados em gaiolas individuais, durante 14 dias. Os tratamentos variaram somente nos níveis de β-glucanos que foram de 35, 70, 140 e 280g/T. No final desse período, em metade dos animais foram injetados 2,7mg de lipopolissacarídeo (LPS) em 1mL de solução (PBS)/leitão, e nos demais 1mL/leitão de PBS. Foram avaliadas temperatura retal (TR), frequência respiratória (FR), perfil bioquímico sanguíneo e sinais clínicos aos 30, 90, 120 e 390 minutos seguintes à injeção. As respostas de desempenho não foram afetadas pelos níveis de β-glucanos. Foi observado o aumento de TR, tanto em função do LPS como em função da hora em que a temperatura foi medida. No entanto, os animais LPS-injetados, que receberam 280g/T de β-glucanos, tiveram a mesma TR daqueles LPS-não injetados. Os sinais clínicos foram compatíveis com um quadro de inflamação aguda e foram observados, nos animais LPS-injetados, vômito, prostração e diarreia, sendo que a inclusão de β-glucanos não conseguiu reverter esses sintomas. O uso de β-glucanos por 14 dias na dieta de leitões recém-desmamados mostrou um efeito anti-inflamatório em situação de desafio agudo. Para reverter o desafio imunológico utilizado, o nível de 280g/T de β-glucanos mostrou-se o mais recomendado.

This study was done to evaluate immunological responses and performance of weaning piglets receiving diets with different levels of β-glucans. Thirty males from a commercial line with 34 days of age and 10.9±0,6kg initial weight were housed in individual metabolic cages during 14 days. The treatments only differed in β-glucans levels: 35; 70; 140 and 280g/T. On the 14th day, half of the pigs were inoculated with 2.7mg LPS (lipopolysaccharide)/mL of solution (PBS)/pig and the other half received 1mL PBS/pig. Rectal temperature (RT), respiratory frequency (RF), biochemical profile and animal behavior (120 and 390 minutes after LPS inoculation) were evaluated. As the experiment was conducted, performance was not affected by β-glucans. An RT increase was observed due to LPS and time of temperature measurement. LPS-injected animals receiving 280g/T of β-glucans had the same RT as the LPS- non injected group. Clinical signs were near the expectation for acute inflammation. LPS-injected presented prostration, diarrhea and vomit and the β-glucans did not reverse this situation. The use of β-glucans in weaning pigs for fourteen days showed an anti-inflammatory action. To revert the immunologic challenge, the level of 280g/T of β-glucans was the most recommended.

Prevalence of antibodies to human herpesvirus-8 in populations with and without risk for infection in São Paulo State

Human herpesvirus 8 (HHV-8) is a newly described herpesvirus that is etiologically associated with all forms of Kaposi's sarcoma (KS). Seroepidemiological studies have shown high prevalence rates of HHV-8 antibodies among men who have sex with men (MSM) and AIDS patients, African children, Brazilian Amerindians, and elderly individuals in certain regions of Europe. The aim of the present study was to determine the prevalence of HHV-8 antibodies in healthy children and young adults from different cities in São Paulo State, and in a population at high risk for HHV-8 infection: HIV-negative MSM, and AIDS patients with and without KS. Antibodies to HHV-8 latency-associated nuclear antigen and lytic-phase antigens were detected by immunofluorescence assays. In 643 healthy children and young adults from the general population attending a vaccination program for yellow fever in ten different cities in São Paulo State, the prevalence of HHV-8 antibodies detected by the presence of latent or lytic antigens ranged from 1.0 to 4.1 percent in the different age groups (mean = 2.5 percent). In the MSM group, the prevalence was 31/95 (32.6 percent). In the group of patients with AIDS, the prevalence was 39.2 percent (51/130) for non-KS patients and 98.7 percent (77/78) for AIDS patients with the diagnosis of KS confirmed by histopathological examination. We conclude that HHV-8 has a restricted circulation among healthy children and young adults in the general population of São Paulo State and a high prevalence among MSM and AIDS patients.